Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
Cost Containment Goes To A New Level with DRG Trial and Renewed Corruption Campa...
Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on China's renewed efforts to contain healthcare costs throu... (6/30/2017)
   
Cancer in the Asia-Pacific, a CRO Perspective (7/13/2017)
Fast-tracking the Introduction of New Drugs (7/13/2017)
Branded Generics in the Emerging Markets (7/12/2017)
FT: Fosun Shares Slide As Group Denies Loss of Contact With Chairman (7/7/2017)
Why Big Pharma Is Targeting China's Deadliest Diseases (7/5/2017)
Cost Containment Goes To A New Level with DRG Trial and Renewed Corruption Campaign (6/30/2017)
How Do You Solve a Problem Like China's Public Health Care? (6/29/2017)
WSJ: Novo Nordisk Wagers Sales Growth Will Offset Price Cuts In China (6/28/2017)
China's New Cybersecurity Law And Draft Data Localization Measures Expected To Burden Multinational Companies (6/22/2017)
CFDA's New Draft Policy Introduces the Chinese Version of Patent Linkage (6/15/2017)
APAC Is the Fastest Growing Market for CRO Industry (6/15/2017)
Alzheimer's Is China's Biggest Future Health Problem - And Biggest Healthcare Industry Opportunity (6/6/2017)
ASIA: Preferred Destination for Clinical Trials (6/6/2017)
Why Europe Is Resorting to China for Its Penicillin Supply (6/5/2017)
Out of the Blue, CFDA Makes Giant Steps Forward to Boost Drug Innovation and IP Protection (6/5/2017)
Performance Snapshot of 18 Chinese Pharm...  (7/21/2017)
Latest Data Set from SMEI: China's Pharm...  (7/21/2017)
Recent Executive Moves  (7/21/2017)
Snapshot of Eli Lilly's Flat Chinese Urb...  (7/21/2017)
CFDA Hosts 2017 BRICs Cooperation Meetin...  (7/20/2017) (free)
CFDA Releases List of Reference Formulat...  (7/20/2017)
SillaJen and Lee's Pharma Approved to Co...  (7/20/2017)
Indegene Unveils New Survey of Digital H...  (7/20/2017)
China Accepts Propanc Biopharma's Patent...  (7/20/2017)
Cardinal Health Plans to Sell China Busi...  (7/20/2017)
MOHRSS Announces Outcome of NRDL Listing...  (7/19/2017)
State Council Reports Healthcare Reform ...  (7/19/2017) (free)
Ascentage Granted IND Approval for Bcl-2...  (7/18/2017)
CFDA Approves Clinical Trial of CStone's...  (7/18/2017)
Luye Life Sciences Expands Global Reach ...  (7/18/2017)
White House Task Force Echoes Pharma Proposals
Pharma Industry Reputation Rebounds Somewhat in 2016
Fresenius Steps Up Pharma M&A with Akorn, Merck ...
Global Pharmerging Market to Grow at a CAGR of 12.88% in...
PhRMA Urges USTR to Protect US Innovation Abroad
Latest Data Set from SMEI: China's Pharma Market Growth Down to...
Chinese Retail Drug Sales Growth Flat in the First Half of 2017...
New Report: Chinese Pharmaceutical Retail Market Growth Slows S...
Analysis: New Product Additions of 2017 NRDL
Snapshot of Drug Sales of Representative Hospitals in Shanghai ...
Performance Snapshot of 18 Chinese Pharma Companies Newly Li...
Snapshot of Eli Lilly's Flat Chinese Urban Hospital Drug Sal...
Indegene Unveils New Survey of Digital Healthcare Communicat...
Cardinal Health Plans to Sell China Business and Exit the Co...
Luye Life Sciences Expands Global Reach as New Boston R&...
CFDA Hosts 2017 BRICs Cooperation Meeting on Drug Regula...
CFDA Releases List of Reference Formulations for Generic...
Review of Drug Applications under Special Approval, Nati...
CFDA Issues Announcement for Package Insert Revision of ...
CFDA Vice Minister Meets Senior Delegation of GAVI Allia...
Shareholders Files Class Action against Sinovac over Bribery...
DSM Sinochem Wins Indian Patent Lawsuit against Sinopharm We...
I-MAK Challenges Gilead's Remaining Patents of HCV Drug Sofo...
China, India Named and Shamed by USTR on Lax IP
PhRMA Criticizes China Over Failure to Uphold Data Exclusivi...
Another Chinese API Producer in Data Integrity Mudpool a...
U.S. FDA Warns Chinese API Producer for Absence of Writt...
India to Make Key APIs to Reduce Dependence on China
DSM Sinochem Pharmaceuticals Boosts Manufacturing Capaci...
U.S. FDA Raises Concerns over Teva's Plant In China
SillaJen and Lee's Pharma Approved to Commence Phase III...
China Accepts Propanc Biopharma's Patent Application for...
Ascentage Granted IND Approval for Bcl-2/Bcl-XL inhibito...
CFDA Approves Clinical Trial of CStone's Fully Human, Fu...
Snapshot of Domestically R&D and IND Filings of ...
MOHRSS Announces Outcome of NRDL Listing Negotiation
State Council Reports Healthcare Reform Progress
NHFPC Issues Notice for Service Model Transformation of ...
NHFPC and SATCM Issue Joint Notice for Reform of Central...
State Council Issues New Guidance Policy for BMI Payment...
Recent Executive Moves
Executive Movements
CFDA Official Moves
Recent Executive Moves
Recent Executive Moves
Upcoming Event: Biopharma Development & Producti...
Upcoming Event: 4th Annual PharmaCon Asia
Upcoming Event: ISPE Conference and Exhibition 2017
Upcoming Event: International Pharma Regulatory Summit
Upcoming Event: Risk Management in Clinical Practice: To...
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links